论文信息 - Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). - 字舞流文

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

Michael Thomas | G. Rustin | N. Lemoine | M. Levine | Z. Kadziola | A. Kakkar | H. Patel | V. Low | M. Quigley | R. Williamson